Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. Led by the former AveXis leadership team and backed by Deerfield Management, a healthcare-specific investment firm, Jaguar brings streamlined R&D, manufacturing and clinical operations to accelerate development and potential approval of therapies for severe genetic diseases.

Biotechnology

Jaguar Gene Therapy

Joe Nolan

Sejal Patel

Kalyn Bauldwin

Michael DePetrillo

Kathy Powell

Patrick Ryan, Ph.D.

Michael Hughes

Keñya Edmondson

Tony Mitchell

Shannon Lindberg

Bryan Grice

James R. Goff

Michael Johannesen

Leadership Team

Legal and Compliance

Research and Development

Engineering and Operations

Teams at Jaguar Gene Therapy

Leadership Team

Legal and Compliance

Research and Development

Engineering and Operations